1. Home /
  2. Biotechnology

Biotechnology

3 Small Biotechs That Came Up Big on Thursday

3 Small Biotechs That Came Up Big on Thursday

Portola Pharmaceuticals, Flexion Therapeutics and BioDelivery Sciences delivered nice third-quarter numbers.

Eli Lilly Could Hit New Highs, but Market Weakness Could Mute Gains

Eli Lilly Could Hit New Highs, but Market Weakness Could Mute Gains

It shouldn't hurt that the drugmaker beat third-quarter estimates and raised its profit guidance for all of 2018.

Small Biotechs Finally Join in Market Rebound

Small Biotechs Finally Join in Market Rebound

Exelixis Inc. and Aratana Therapeutics in particular surge after posting solid results Thursday.

Why Investors Should Favor Smaller Biotech Companies

Why Investors Should Favor Smaller Biotech Companies

Small and mid-cap biotech firms are driving innovation in the sector. Experts explain why investors should take notice.

Novartis Secures Prostate Cancer Treatment With Endocyte Deal

Novartis Secures Prostate Cancer Treatment With Endocyte Deal

The Swiss drugmaker will pay $2.1 billion for Endocyte, justifying the Nasdaq-listed biotech's pivot to prostate treatment last year.

As Canada OKs Pot, Research Advances Could Follow

As Canada OKs Pot, Research Advances Could Follow

As Canada becomes the second country after Uruguay to allow recreational use of cannabis, advances in pot research could follow.

Biotech and Broadway Come Together to Fight Cancer

Biotech and Broadway Come Together to Fight Cancer

Cancer affects all of us. But the Damon Runyon Cancer Research Foundation has invested $355 million (and counting) in research to fight it. We spent time with its incoming CEO to hear about her journey and how immunotherapies are taking the lead.

3 Biotech Stocks Ready to Burn Up

3 Biotech Stocks Ready to Burn Up

Biotechs are known for wild tears. Investors, you'll want to consider these drug makers.

3 Biotech Stock Favorites to Bet on Today: Top Analysts

3 Biotech Stock Favorites to Bet on Today: Top Analysts

Follow the experts. These biotech stocks have Wall Street's best analysts getting bullish.

This Company Is at the Center of Insider Trading Charges Against Rep. Collins

This Company Is at the Center of Insider Trading Charges Against Rep. Collins

Innate Immunotherapeutics of Australia is the biopharmaceutical company at the center of the insider trading charges leveled against New York Rep. Chris Collins.